NSE ScannerChemicals · Chemicals: Specialty · NSE: CENTENKA · data 2026-10-30
Century Enka Limited
In plain words
Price: 32.2% below its 52-week high of ₹671.65.
Delivery: 43.3% of traded shares were kept for delivery over the last 10 sessions, against 49.1% over the last 60.
Latest results: a net profit of ₹18 cr for the quarter ended Sept 2026 (-18.4% on the same quarter a year earlier).
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹2,008 cr |
| Net profit (last 12 months) | ₹143 cr |
| Sales growth, 3 years (yearly) | -6.3% |
| Profit growth, 3 years (yearly) | 3.7% |
Latest results in brief (Q2 FY27)
CENTENKA Q2 FY27 results (consolidated figures, as filed on NSE).
Revenue was ₹558.23 crore, up 36.6% YoY and up 0.7% QoQ.
Net profit was ₹18.49 crore, down 18.4% YoY and down 70% QoQ.
Operating margin was 5.9% (7.7% a year ago).
EPS was ₹8.46, down 17.2% YoY and down 70% QoQ.
CENTENKA के Q2 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।
राजस्व: ₹558.23 करोड़; पिछले साल की तुलना में 36.6% की बढ़त, पिछली तिमाही की तुलना में 0.7% की बढ़त।
शुद्ध मुनाफ़ा: ₹18.49 करोड़; पिछले साल की तुलना में 18.4% की गिरावट, पिछली तिमाही की तुलना में 70% की गिरावट।
ऑपरेटिंग मार्जिन: 5.9% (एक साल पहले 7.7%)।
EPS: ₹8.46; पिछले साल की तुलना में 17.2% की गिरावट, पिछली तिमाही की तुलना में 70% की गिरावट।
CENTENKAના Q2 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹558.23 કરોડ; ગયા વર્ષની સરખામણીએ 36.6% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 0.7% વધારો.
ચોખ્ખો નફો: ₹18.49 કરોડ; ગયા વર્ષની સરખામણીએ 18.4% ઘટાડો, ગયા ક્વાર્ટરની સરખામણીએ 70% ઘટાડો.
ઓપરેટિંગ માર્જિન: 5.9% (એક વર્ષ પહેલાં 7.7%).
EPS: ₹8.46; ગયા વર્ષની સરખામણીએ 17.2% ઘટાડો, ગયા ક્વાર્ટરની સરખામણીએ 70% ઘટાડો.
Written from the filed numbers. Not a recommendation.
Smart-money activity
33/100 · Neutral over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 14/30: Delivery 35.3% over the last 20 sessions vs 12.0% in the 40 before (2.94x); shares delivered per day 0.49x usual; 1 delivery-spike day (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 14/20: Net +₹2.25 cr bought in bulk/block deals over 90 days (0.8x a usual day's traded value); 1 net buying day, 0 net selling days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Results ● Deal ● Dividend
- 27 Oct 26Results Q2 FY27 results: profit −18.4% YoY -11.0% next session
- 2 Sept 26Deal Bulk deal: IRAGE BROKING SERVICES LLP +1 bought ₹2.25 cr +13.3% next session
- 13 Aug 26Dividend Dividend ₹11 (ex-date) -5.8% next session
- 28 Jul 26Results Q1 FY27 results: profit +301.2% YoY +5.8% next session
- 21 May 26Results Q4 FY26 results: profit +482.8% YoY +15.9% next session
- 6 Feb 26Results Q3 FY26 results: profit +69.6% YoY +3.0% next session
- 6 Nov 25Results Q2 FY26 results: profit +5.9% YoY -2.5% next session
- 5 Aug 25Dividend Dividend ₹10 (ex-date) -0.6% next session
- 1 Aug 25Results Q1 FY26 results: profit −36.8% YoY -3.7% next session
- 6 May 25Results Q4 FY25 results: profit −66.7% YoY -16.3% next session
- 11 Feb 25Results Q3 FY25 results: profit +199.6% YoY -13.0% next session
- 8 Nov 24Results Q2 FY25 results: profit +398.8% YoY -5.7% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Sept 2026 | ₹558 cr | ₹18 cr | -18.4% | 5.9% | 8.46 |
| Jun 2026 | ₹554 cr | ₹62 cr | +301.2% | 15.5% | 28.24 |
| Mar 2026 | ₹484 cr | ₹39 cr | +482.8% | 11.5% | 18.03 |
| Dec 2025 | ₹412 cr | ₹24 cr | +69.6% | 9.9% | 10.86 |
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 24.86% | 24.86% | 24.86% | 24.86% |
| Foreign institutions (FII) | 2.60% | 1.96% | 2.06% | 2.12% |
| Domestic institutions (DII) | 8.94% | 10.91% | 11.04% | 11.03% |
| Mutual funds | 7.89% | 9.85% | 9.98% | 9.98% |
| Retail investors | 29.63% | 28.96% | 28.75% | 29.15% |
| Number of shareholders | 40,820 | 37,239 | 36,944 | 37,439 |
Common questions
What was Century Enka Limited's latest quarterly profit?
Century Enka Limited reported a net profit of ₹18 cr for the quarter ended Sept 2026 (-18.4% on the same quarter a year earlier), on revenue of ₹558 cr.
How much do promoters hold in Century Enka Limited?
Promoters held 24.86% of Century Enka Limited at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is Century Enka Limited debt-free?
Its latest reported debt-to-equity ratio is 0.01, which is very low.
What is Century Enka Limited's P/E ratio?
About 6.9, based on the last 12 months' earnings and a price of ₹455.3 (data 2026-10-30).
What is the 52-week high and low of Century Enka Limited?
The 52-week high is ₹671.65 and the 52-week low is ₹371.2.
Similar companies
Valiant Organics Limited (VALIANTORG) · TGV SRAAC Ltd (TGVSL) · Andhra Sugars Limited (ANDHRSUGAR) · Ultramarine & Pigments Limited (ULTRAMAR) · Tamilnadu Petro Products Ltd. (TNPETRO)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open CENTENKA in NSE Scanner →